Cartesian Therapeutics (RNAC) Asset Utilization Ratio (2016 - 2025)
Historic Asset Utilization Ratio for Cartesian Therapeutics (RNAC) over the last 10 years, with Q3 2025 value amounting to 0.0.
- Cartesian Therapeutics' Asset Utilization Ratio fell 9760.02% to 0.0 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.0, marking a year-over-year decrease of 9760.02%. This contributed to the annual value of 0.11 for FY2024, which is 477.7% down from last year.
- According to the latest figures from Q3 2025, Cartesian Therapeutics' Asset Utilization Ratio is 0.0, which was down 9760.02% from 0.0 recorded in Q2 2025.
- In the past 5 years, Cartesian Therapeutics' Asset Utilization Ratio registered a high of 0.76 during Q2 2022, and its lowest value of 0.0 during Q2 2025.
- For the 5-year period, Cartesian Therapeutics' Asset Utilization Ratio averaged around 0.31, with its median value being 0.26 (2021).
- Its Asset Utilization Ratio has fluctuated over the past 5 years, first soared by 44299.0% in 2021, then tumbled by 9840.08% in 2025.
- Cartesian Therapeutics' Asset Utilization Ratio (Quarter) stood at 0.52 in 2021, then rose by 23.74% to 0.64 in 2022, then crashed by 80.35% to 0.13 in 2023, then crashed by 30.91% to 0.09 in 2024, then tumbled by 96.72% to 0.0 in 2025.
- Its Asset Utilization Ratio was 0.0 in Q3 2025, compared to 0.0 in Q2 2025 and 0.08 in Q1 2025.